Literature DB >> 19277403

Cell-derived microparticles in haemostasis and vascular medicine.

Laurent Burnier1, Pierre Fontana, Brenda R Kwak, Anne Angelillo-Scherrer.   

Abstract

Considerable interest for cell-derived microparticles has emerged, pointing out their essential role in haemostatic response and their potential as disease markers, but also their implication in a wide range of physiological and pathological processes. They derive from different cell types including platelets - the main source of microparticles - but also from red blood cells, leukocytes and endothelial cells, and they circulate in blood. Despite difficulties encountered in analyzing them and disparities of results obtained with a wide range of methods, microparticle generation processes are now better understood. However, a generally admitted definition of microparticles is currently lacking. For all these reasons we decided to review the literature regarding microparticles in their widest definition, including ectosomes and exosomes, and to focus mainly on their role in haemostasis and vascular medicine.

Entities:  

Mesh:

Year:  2009        PMID: 19277403

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  129 in total

1.  Correlation between platelet-derived microparticle enumeration by flow cytometry and phospholipid-dependent procoagulant activity in microparticles: the centrifugation step matters!

Authors:  Jérémie Stagnara; Francine Garnache Ottou; Fanny Angelot; Guillaume Mourey; Estelle Seilles; Sabéha Biichlé; Philippe Saas; Evelyne Racadot
Journal:  Thromb Haemost       Date:  2012-04-04       Impact factor: 5.249

2.  Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay.

Authors:  Armando Tripodi; Adriana Branchi; Veena Chantarangkul; Marigrazia Clerici; Giuliana Merati; Andrea Artoni; Pier Mannuccio Mannucci
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

3.  New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells.

Authors:  Katie Grimshaw; Julie Sahler; Sherry L Spinelli; Richard P Phipps; Neil Blumberg
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

4.  Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.

Authors:  Miroslaw Kornek; Michael Lynch; Shruti H Mehta; Michelle Lai; Mark Exley; Nezam H Afdhal; Detlef Schuppan
Journal:  Gastroenterology       Date:  2012-04-24       Impact factor: 22.682

5.  Microparticles in stored red blood cells as potential mediators of transfusion complications.

Authors:  Wenche Jy; Marco Ricci; Sherry Shariatmadar; Orlando Gomez-Marin; Lawrence H Horstman; Yeon S Ahn
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

Review 6.  Infusible platelet membrane as a platelet substitute for transfusion: an overview.

Authors:  Saleh Nasiri
Journal:  Blood Transfus       Date:  2013-05-14       Impact factor: 3.443

7.  Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease.

Authors:  Mutlu Kasar; Can Boğa; Mahmut Yeral; Suheyl Asma; Ilknur Kozanoglu; Hakan Ozdogu
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 8.  Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms.

Authors:  Somedeb Ball; Kyaw Zin Thein; Abhishek Maiti; Kenneth Nugent
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

9.  Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner.

Authors:  Jian-Guo Wang; Julie C Williams; Beckley K Davis; Ken Jacobson; Claire M Doerschuk; Jenny P-Y Ting; Nigel Mackman
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

10.  Short term statin treatment improves survival and differentially regulates macrophage-mediated responses to Staphylococcus aureus.

Authors:  Erin M Burns; Lisa K Smelser; Jenny E Then; Traci E Stankiewicz; Michael Kushdilian; Susan A McDowell; Heather A Bruns
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.